"As the premier provider of urologic care in Southern Nevada, we offer outstanding physicians, state-of-the-art technology, comprehensive clinical facilities and our dedication to create the best possible patient care experience. Our team is dedicated to improving the lives of our patients by offering the most current diagnostic and therapeutic alternatives available. We treat our patients as we would like to be treated."

During the past decade, Las Vegas Urology - Pebble conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 7 clinical trials were completed, i.e. on average, 8.9% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 7 clinical trials were completed. i.e. 17.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Las Vegas Urology - Pebble" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "Children's Oncology Group" with 11 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Las Vegas Urology - Pebble" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Las Vegas Urology - Pebble" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials) and "Stage IVB Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Las Vegas Urology - Pebble" in a lesser frequency.

Most popular intervention types in "Las Vegas Urology - Pebble" are "Drug" (60 trials), "Other" (45 trials), "Biological" (38 trials), "Procedure" (31 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (21 trials), "Quality-of-Life Assessment" (21 trials), "Computed Tomography" (20 trials), "Questionnaire Administration" (16 trials) and "Laboratory Biomarker Analysis" (13 trials). Other intervention names were less common.

The vast majority of trials in "Las Vegas Urology - Pebble" are 73 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Las Vegas Urology - Pebble". undefined are not yet recruiting, 38 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Las Vegas Urology - Pebble, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Las Vegas Urology - Pebble, 1 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".